Blepharitis Treatment Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Blepharitis

 

Blepharitis is a common eyelid condition characterized by redness, flaking and crusting of eyelashes and eyelid margin. It occurs due to bacterial or skin infection around the eyelids. Blepharitis causes irritation, itching, burning sensation and discomfort in eyes. Common symptoms include dry, gritty or burning eyes, swollen or reddened eyelids, dandruff-like flakes near the base of the eyelashes and eyelashes sticking together after waking up. Blepharitis needs to be treated as it can lead to more severe vision issues like blurred vision, eye fatigue and risk of eye infection if left untreated. With rising prevalence of blepharitis due to increasing pollution, use of digital devices and aging population, the blepharitis treatment market is witnessing significant growth.

The Global blepharitis treatment market is estimated to be valued at US$ 2.5 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period of 2023 to 2030.

Key Takeaways

Key players operating in the blepharitis treatment market are Scope Ophthalmic Ltd., NovaBay Pharmaceuticals Inc., Thea Pharmaceuticals Ltd., Perrigo Laboratories, InSite Vision Incorporated, Merck & Co., and Novartis AG. These players are focusing on new product launches, licensing agreements and collaborative partnerships to strengthen their market position.

There is high product demand for eye drops, gels, ointments and liquids used for eyelid hygiene and warm compresses, which offers significant growth opportunities. With increasing blepharitis prevalence, anti-inflammatory and antibiotic products are majorly contributing to market revenues.

European and North American markets dominated global blepharitis treatment sales in 2021. However, Asia Pacific region is expected to witness highest growth rate owing to large patient pool, increasing healthcare expenditure and rising medical tourism. Key players are expanding their manufacturing and distribution footprint in emerging countries to tap high potential markets.

Market Drivers
Increasing geriatric population suffering from blepharitis: Growing aging population and rising life expectancy have increased prevalence of chronic and infectious eye diseases including blepharitis. Elderly people over 60 years of age are at higher risk of developing blepharitis.

Growing pollution levels and screen time: Rising air pollution from vehicular exhaust and industrial emissions have aggravated blepharitis symptoms. Increased dependence on digital devices and extended screen viewing hours have deteriorated eye health and blepharitis incidence.

Market Restrains
Side effects associated with topical ophthalmic drugs: Topical antibiotic, anti-inflammatory and steroid eye drops used in blepharitis treatment may cause irritation, redness, burning sensation, itching, stinging and blurred vision.

Lack of disease awareness in developing nations: Low blepharitis awareness due to lack of health education initiatives and screening programs hinders diagnosis and treatment-seeking rates in underdeveloped regions.

Segment Analysis

The blepharitis treatment market can be segmented based on type, drug class, distribution channel, and geography. Based on type, the market is segregated into anterior blepharitis and posterior blepharitis. The anterior blepharitis segment presently accounts for the lion's share of the overall market as it is the most prevalent type affecting around 50% of the population. Based on drug class, the market is bifurcated into antibiotics, steroids, and others. The antibiotic segment dominates the market as they remain the first line of treatment for blepharitis. Based on distribution channels, the blepharitis treatment market is divided into hospital pharmacies, retail pharmacies, online pharmacies. Retail pharmacies account for the largest share of the distribution channel segment due to the easy accessibility of OTC drugs.

Regional Analysis

North America is expected to dominate the global blepharitis treatment market during the forecast period. This is attributed to factors such as the rising prevalence of eye diseases, advancements in treatment technologies, well-developed healthcare infrastructure, favorable reimbursement policies, and the presence of major players in the region. Additionally, Asia Pacific is anticipated to witness the fastest growth during the forecast period. Factors such as the growing geriatric population, increasing healthcare expenditure, improving access to healthcare facilities and rising awareness about eye disorders are driving the growth of the blepharitis treatment market in the Asia Pacific region.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more